| Original language | English |
|---|---|
| Pages (from-to) | 241-250 |
| Journal | Cancer Immunology and Immunotherapy |
| Volume | 40 |
| Publication status | Published - 1995 |
Cite this
Bielefeldt-Ohmann, H., Marzo, A. L., Himbeck, R., Jarnicki, A. G., & Robinson, B. (1995). Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy. Cancer Immunology and Immunotherapy, 40, 241-250.
@article{663e89f8613f42448042d876b56cad88,
title = "Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy",
author = "H. Bielefeldt-Ohmann and A.L. Marzo and Robyn Himbeck and A.G. Jarnicki and Bruce Robinson",
year = "1995",
language = "English",
volume = "40",
pages = "241--250",
journal = "Cancer immunology, immunotherapy",
issn = "0340-7004",
publisher = "Springer",
}
Bielefeldt-Ohmann, H, Marzo, AL, Himbeck, R, Jarnicki, AG & Robinson, B 1995, 'Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy' Cancer Immunology and Immunotherapy, vol. 40, pp. 241-250.
Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy. / Bielefeldt-Ohmann, H.; Marzo, A.L.; Himbeck, Robyn; Jarnicki, A.G.; Robinson, Bruce.
In: Cancer Immunology and Immunotherapy, Vol. 40, 1995, p. 241-250.Research output: Contribution to journal › Article
TY - JOUR
T1 - Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy
AU - Bielefeldt-Ohmann, H.
AU - Marzo, A.L.
AU - Himbeck, Robyn
AU - Jarnicki, A.G.
AU - Robinson, Bruce
PY - 1995
Y1 - 1995
M3 - Article
VL - 40
SP - 241
EP - 250
JO - Cancer immunology, immunotherapy
JF - Cancer immunology, immunotherapy
SN - 0340-7004
ER -
Bielefeldt-Ohmann H, Marzo AL, Himbeck R, Jarnicki AG, Robinson B. Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy. Cancer Immunology and Immunotherapy. 1995;40:241-250.